The European Commission has approved Hungarian pharmaceutical company Gedeon Richter's drug RYEQO for tge treatment of endometriosis symptoms, Richter and peer Sumitomo Pharma said this week, according to a report by state news wire MTI.
/PRNewswire/ Sumitomo Pharma America, Inc. (SMPA) today announced preliminary clinical data for investigational agents TP-3654, a selective oral PIM1 kinase.
European Commission Approves the Commercialisation of RYEQO® for the Symptomatic Treatment of Endometriosis streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The Japanese stock market is sharply higher on Wednesday, adding to the gains in the previous session, following the broadly positive cues from global markets overnight.